title: [Progress in cancer treatment with histone deacetylase inhibitor].
authors.affiliation: Email: syuankaipumc@126.com.
authors.forename: Mei
authors.initials: M
authors.lastname: Dong
authors.forename: Xing-sheng
authors.initials: XS
authors.lastname: Hu
authors.forename: Shan-shan
authors.initials: SS
authors.lastname: Chen
authors.forename: Pu-yuan
authors.initials: PY
authors.lastname: Xing
authors.forename: Feng-yi
authors.initials: FY
authors.lastname: Feng
authors.forename: Yuan-kai
authors.initials: YK
authors.lastname: Shi
mesh_terms: D000631:Aminopyridines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D047630:Depsipeptides / Q000627:therapeutic use; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006655:Histone Deacetylases / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D000077767:Panobinostat; D013449:Sulfonamides / Q000627:therapeutic use; D000077337:Vorinostat
chemical_list: D000631:Aminopyridines; D000970:Antineoplastic Agents; D001549:Benzamides; D047630:Depsipeptides; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D007211:Indoles; D013449:Sulfonamides; D000077337:Vorinostat; C547816:N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide; D000077767:Panobinostat; C087123:romidepsin; D006655:Histone Deacetylases; C487081:belinostat